                                                               
 
July 8, 2024 
 
National Stock Exchange of India Limited 
Exchange Plaza, Plot No. C/1, G Block, 
Bandra Kurla Complex, Bandra (E), 
Mumbai – 400 051. 
Symbol: RAINBOW 
BSE Limited 
Corporate Relationship Department, 
Phiroze Jeejeebhoy Towers, 
Dalal Street, Mumbai – 400001. 
Scrip Code: 543524 
 
Sub: Business Responsibility and Sustainability Report for the Financial Year 2023-24 
 
Ref: Pursuant to Regulation 34(2)(f) of the SEBI (Listing Obligations and Disclosure 
Requirements) Regulations 2015 ("Listing Regulations") 
 
Dear Sir/ Madam, 
 
Pursuant to the provisions of Regulation 34(2)(f) of the Listing Regulations, please find 
attached copy of Business Responsibility and Sustainability Report of the Company for the 
Financial Year 2023-24, which also forms part of the Integrated Annual Report for the Financial 
Year 2023-24, submitted to the Stock Exchanges vide letter dated July 8, 2024. 
 
We request you to kindly take the same on record. 
 
Thanking You, 
 
Yours Faithfully, 
 
For Rainbow Children’s Medicare Limited 
 
 
Ashish Kapil 
Company Secretary and Compliance Officer 
 
Encl.: As above 
ASHISH 
KAPIL
Digitally signed 
by ASHISH KAPIL 
Date: 2024.07.08 
20:06:00 +05'30'
01
SECTION A: GENERAL DISCLOSURES
I.	
Details of the listed entity 
1.
Corporate Identity Number (CIN) of the Listed Entity
L85110TG1998PLC029914
2.
Name of the Listed Entity 
Rainbow Children’s Medicare Limited 
("the Company/Rainbow/Rainbow Hospitals/
Rainbow Children's Hospital/ RCML")
3.
Year of incorporation 
1998
4.
Registered office address 
8-2-120/103/1, Survey No. 403, Road No. 2, 
Banjara Hills, Hyderabad – 500034, Telangana.
5.
Corporate address
8-2-19/1/A, Daulet Arcade, Karvy Lane, Road No.11, 
Banjara Hills, Hyderabad - 500034, Telangana.
6.
E-mail 
companysecretary@rainbowhospitals.in
7.
Telephone
+91 40 49692244
8.
Website
www.rainbowhospitals.in 
9.
Financial year for which reporting is being done 
FY 24 (2023-24)
10. Name of the Stock Exchange(s) where shares are listed 1.	
National Stock Exchange of India Limited
2.	
BSE Limited
11. Paid-up Capital 
INR 101.50 Cr
12. Name and contact details (telephone, email address) 
of the person who may be contacted in case of any 
queries on the BRSR report 
Mr. Ashish Kapil
Company Secretary & Compliance Officer
Tel No: +91 40 49692244
Email ID: companysecretary@rainbowhospitals.in
13. Reporting boundary - Are the disclosures under this 
report made on a standalone basis (i.e. only for the 
entity) or on a consolidated basis (i.e. for the entity and 
all the entities which form a part of its consolidated 
financial statements, taken together).
Consolidated basis unless otherwise specified
14. Name of assurance provider 
Not applicable as the Company does not fall under 
the purview of External Assurance as per SEBI 
Requirements
15. Type of assurance obtained
-
II.	
Product/Services 
	
16.	 Details of business activities (accounting for 90% of the turnover):
Sr. 
No.
Description of Main Activity 
Description of Business Activity 
% of Turnover of the entity 
1
Human Health Activities
Revenue from Hospital and other 
Medical services
100
	
17.	 Products/Services sold by the entity (accounting for 90% of the entity’s Turnover):
Sr. 
No.
Product/Service 
NIC Code 
% of total Turnover contributed 
1
Human Health Activities
86100
100
Business Responsibility 
& Sustainability Report
Integrated Annual Report 2023-24
Rainbow Children's Medicare Limited
02
III.	
Operations 
	
18.	 Number of locations where plants and/or operations/offices of the entity are situated:
Location
Number of Plants
Number of Offices
Total
National
No. of hospitals: 19 No. of clinics: 4
1
24
International
-
-
-
	
19.	 Markets served by the entity 
	
	
a.	
Number of locations 
Location
Number 
National (No. of States)
5
International (No. of Countries)
None
	
	
b.	
What is the contribution of exports as a percentage of the total turnover of the entity?
	
	
	
The Company has presence in 5 states. The Company does not export & thus there is no contribution of 
exports to the turnover of the entity. The patients, however, include Indian citizens as well as citizens of 
foreign nationalities, who visit our hospitals in India for availing healthcare services.
	
	
c.	
A brief on types of customers
	
	
	
Rainbow Children's Hospital caters to a diverse range of customers, including patients seeking medical 
assistance and healthcare services. These may encompass individuals in need of specialized medical 
treatments, routine check-ups, surgical procedures, maternity care, paediatric care, and more.
IV.	
Employees
	
20.	 Details as at the end of financial year:
	
	
a.	
Employees and workers (including differently abled):
Sr. 
No.
Particulars
Total (A)
Male
Female
No.(B)
%(B/A)
No.(C)
%(C/A)
EMPLOYEES
1.
Permanent(D)
3,940
1,663
42%
2,277
58%
2.
Other than Permanent (E)#
1,535
422
27%
1,113
73%
3.
Total employees (D+E)
5,475
2,085
38%
3,390
62%
WORKERS*
4.
Permanent(F)
Not Applicable
5.
Other than Permanent (G)
6.
Total workers (F+G)
	
	
	
*Rainbow Hospitals does not employ workers
	
	
	
# Other than Permanent (E) includes:
 
 
 
• 
Trainees
 
 
 
• 
Interns
 
 
 
• 
Full time Doctors
 
 
 
• 
Full time DNBs
 
 
 
• 
Full Times Registrar
	
	
b.	
Differently abled Employees and workers:
Sr. 
No.
Particulars
Total (A)
Male
Female
No.(B)
%(B/A)
No.(C)
%(C/A)
DIFFERENTLY ABLED EMPLOYEES
1.
Permanent(D)
2
0
0
2
100%
2.
Other than Permanent (E)
0
0
0
0
0
3.
Total differently abled 
employees (D+E)
2
0
0
2
100%
DIFFERENTLY ABLED WORKERS
4.
Permanent(F)
Not Applicable
5.
Other than Permanent (G)
6.
Total differently 
abled workers (F+G)
03
Business Responsibility & Sustainability Report
	
21.	 Participation/Inclusion/Representation of women:
Total (A)
Number and percentage of Females
No.(B)
%(B/A)
Board of Directors
7
1
14.29%
Key Management Personnel 
5
0
0%
	
22.	 Turnover rate for permanent employees and workers: 
	
	
(Disclose trends for the past 3 years)
FY 2024
(Turnover rate 
in Current Year)
FY 2023
(Turnover rate 
in Previous Year)
FY 2022
(Turnover rate in the year 
prior to the previous FY)
Male Female
Total
Male Female
Total
Male Female
Total
Permanent Employees
27%
37%
33%
33%
40%
37%
35%
57%
47%
Permanent Workers 
Not Applicable
V.	
Holding, Subsidiary and Associate companies (including joint ventures)
	
23.	 a.	
Names of holding/ subsidiary/ associate companies/ joint ventures 
S. 
No.
Name of the holding/ 
subsidiary/associate 
companies/ joint 
ventures (A)
Indicate whether 
holding/Subsidiary/ 
Associate/Joint 
Venture
% of shares 
held by listed 
entity
Does the entity indicated at 
column A, participate in the 
Business Responsibility initiatives 
of the listed entity? (Yes/No)
1
Rainbow Children’s 
Hospital Private 
Limited
Subsidiary
100%
No
2
Rainbow Speciality 
Hospitals Private 
Limited
Subsidiary
78.81%
No
3
Rainbow Women & 
Children’s Hospital 
Private Limited
Subsidiary
100%
No
4
Rosewalk Healthcare 
Private Limited
Subsidiary
100%
No
5
Rainbow Fertility 
Private Limited
Subsidiary
100%
No
6
Rainbow C R O 
Private Limited
Subsidiary
100%
No
VI.	
CSR Details
	
24.	 (i)	
Whether CSR is applicable as per section 135 of Companies Act, 2013: Yes
	
	
(ii)	
Turnover (in INR): 12,365.62 Millions (Standalone)
	
	
(iii)	 Net worth (in INR): 12,852.51 Millions (Standalone)
Integrated Annual Report 2023-24
Rainbow Children's Medicare Limited
04
VII.	 Transparency and Disclosures Compliances
	
25.	 Complaints/Grievances on any of the principles (Principles 1 to 9) under the National Guidelines on 
Responsible Business Conduct:
Stakeholder 
group from 
whom 
complaint is 
received
Grievance Redressal 
Mechanism in Place 
(Yes/No) (If Yes, then 
provide web-link for 
grievance redress 
policy)
FY 2024
FY 2023
Number of 
complaints 
filed during 
the year
Number of 
complaints 
pending 
resolution 
at close of 
the year
Remarks
Number of 
complaints 
filed during 
the year
Number of 
complaints 
pending 
resolution 
at close of 
the year
Remarks
Shareholders
Yes 
https://www.
rainbowhospitals.in/
investors-relations/
investor-contact
11
Nil
-
1040
Nil
-
Employees 
and workers
Yes 
https://www.
rainbowhospitals.in/
investor-relations/
reports/policy/
Whistle_Blower_
Policy.pdf
2
Nil
-
Nil
Nil
-
Customers
Yes 
https://www.
rainbowhospitals.in/
contact-us
2629
9
-
1065
15
-
Value Chain 
Partners
Yes 
https://www.
rainbowhospitals.in/
investor-relations/
reports/policy/
Whistle_Blower_
Policy.pdf
Nil
Nil
-
2
Nil
-
Investors 
(other than 
shareholders)
Yes 
https://www.
rainbowhospitals.in/
investors-relations/
investor-contact
Nil
Nil
-
Nil
Nil
-
Communities
Yes 
https://www.
rainbowhospitals.in/
investor-relations/
reports/policy/
Whistle_Blower_
Policy.pdf
Nil
Nil
-
Nil
Nil
-
05
Business Responsibility & Sustainability Report
	
26.	 Overview of the entity’s material responsible business conduct issues. Please indicate material responsible 
business conduct and sustainability issues pertaining to environmental and social matters that present a risk 
or an opportunity to your business, rationale for identifying the same, approach to adapt or mitigate the risk 
along-with its financial implications, as per the following format:
S. 
No.
Material issue 
identified
Indicate 
whether 
risk or 
opportunity 
(R/O)
Rationale for 
identifying the risk / 
opportunity
In case of risk, 
approach to adapt or 
mitigate
Financial 
implications of the 
risk or opportunity 
(Indicate positive 
or negative 
implications)
1.
Investments in 
technology and 
digital marketing
Opportunity
By embracing 
digital marketing 
and technology, the 
Company can diversify 
its product portfolio 
and enhance patient 
services, aligning 
with its vision. This 
strategy bolsters 
market presence and 
widens accessibility to 
a broader audience. 
Prioritizing digital 
advancements 
empowers the company 
to innovate and exceed 
customer expectations, 
creating products and 
services that resonate 
effectively.
-
Positive
The Company's 
commitment to 
innovation and 
technology drives 
the enhancement of 
its product portfolio 
and patient services, 
ensuring timely 
access and meeting 
evolving needs. 
This investment 
underscores 
the Company's 
dedication to 
product innovation 
and staying at the 
forefront of industry 
advancements.
2
Occupational 
hazard affecting 
health of 
employees 
(Doctors, Nurses 
& Paramedical 
staff)
Risk
Healthcare 
professionals face 
the inherent risk of 
contracting infections 
while providing care to 
sick patients.
The Company 
prioritizes the well-
being of its staff 
members through 
various initiatives. 
These include 
periodic vaccination 
in accordance with 
guidelines, provision 
of medical and term 
insurance to mitigate 
health and financial 
risks, and offering 
financial support to 
the relatives of staff 
who have lost their 
lives while serving 
patients. Additionally, 
nutritious food is 
provided to nurses 
residing in hostels, 
promoting their 
overall health and 
well-being.
Negative
The company might 
encounter challenges 
such as revenue 
loss and difficulty 
in filling positions 
due to a shortage of 
available manpower. 
These issues can 
negatively affect the 
quality of clinical care 
provided to patients 
and lead to increased 
recruitment costs.
Integrated Annual Report 2023-24
Rainbow Children's Medicare Limited
06
S. 
No.
Material issue 
identified
Indicate 
whether 
risk or 
opportunity 
(R/O)
Rationale for 
identifying the risk / 
opportunity
In case of risk, 
approach to adapt or 
mitigate
Financial 
implications of the 
risk or opportunity 
(Indicate positive 
or negative 
implications)
3
Risk 
Management
Risk & 
Opportunity
Risk
Businesses risk facing 
adverse effects across 
various operational 
areas if they lack robust 
controls within their risk 
management system.
Opportunity
Integrating risk 
management 
into a company’s 
overall strategy 
presents numerous 
opportunities. It 
shields against 
potential disruptions, 
ensuring adaptability 
in a changing business 
landscape. This 
approach fosters 
resilience, bolstering 
sustained success 
despite challenges.
The company 
collaborates with 
key stakeholders in 
the risk management 
process, ensuring 
awareness and 
involvement in 
mitigating potential 
risks. This inclusive 
approach cultivates 
a culture of risk 
awareness and 
accountability, 
resulting in more 
effective risk 
management 
outcomes.
Positive
By proactively 
aligning material 
topics with risk 
mitigation strategies, 
the company can 
foster a more resilient 
and sustainable 
approach to 
growth. Grounded 
in a thorough 
comprehension of 
operational risks 
and opportunities, 
this approach 
enables effective risk 
management and 
the maximization 
of opportunities. 
Embracing this 
method, the company 
can enhance its 
overall performance 
and position itself for 
long-term success.
07
Business Responsibility & Sustainability Report
SECTION B: MANAGEMENT AND PROCESS DISCLOSURES 
This section is aimed at helping businesses demonstrate the structures, policies and processes put in place towards adopting 
the NGRBC Principles and Core Elements.
Disclosure Questions
P1
P2
P3
P4
P5
P6
P7
P8
P9
Policy and management processes 
1.	
a.	
Whether your entity’s policy/policies cover 
each principle and its core elements of the 
NGRBCs. (Yes/No)
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
	
b.	
Has the policy been approved by the Board? 
(Yes/No)
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
	
c.	
Web Link of the Policies, if available.
https://www.rainbowhospitals.in/investor-relations/reports/
policy/Business%20Responsibility%20Policy.pdf
2.	
Whether the entity has translated the policy into 
procedures. (Yes / No)
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
3.	
Do the enlisted policies extend to your value chain 
partners? 
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
4.	
Name of the national and international codes/
certifications/labels/ 
standards 
(e.g. 
Forest 
Stewardship 
Council, 
Fairtrade, 
Rainforest 
Alliance, Trustea) standards (e.g. SA 8000, OHSAS, 
ISO, BIS) adopted by your entity and mapped to 
each principle.
The 
Company 
prioritizes 
Environmental, 
Social, 
and 
Governance (ESG) best practices through a comprehensive 
framework. This framework 
incorporates 
internationally 
recognized standards like ISO 14001 for environmental 
management and IFC guidelines for social and environmental 
risk management. Additionally, we adhere to NABH healthcare 
quality standards, ensuring patient safety and quality of care. 
On the governance front, the Company follows NVG guidelines 
and relevant regulations like Section 135 of the Companies 
Act, 2013 and SEBI (Listing Obligations and Disclosure 
Requirements) 2015, to promote transparency, accountability, 
and responsible business conduct. This commitment to ESG 
principles underscores our dedication to sustainability.
5.	
Specific commitments, goals and targets set by the 
entity with defined timelines, if any.
The Company is committed to follow the impact guidelines for
each of the 9 principles.
6.	
Performance of the entity against the specific 
commitments, 
goals 
and 
targets 
along-with 
reasons in case the same are not met.
The Company continuously monitors its performance against 
the said indicators periodically, take corrective action as 
needed and institutionalise preventive steps to strengthen its 
performance on the said parameter.
Integrated Annual Report 2023-24
Rainbow Children's Medicare Limited
08
Disclosure Questions
P1
P2
P3
P4
P5
P6
P7
P8
P9
Governance, leadership and oversight
7.	
Statement by director responsible for the business responsibility report, highlighting ESG related challenges, 
targets and achievements (listed entity has flexibility regarding the placement of this disclosure)
	
At Rainbow Children's Hospital, sustainability isn't just a checkbox it's the foundation for a thriving future. We 
understand that environmental, social, and governance (ESG) issues are deeply interconnected, and addressing them 
is essential for the well-being of our company, our community, and the planet.
	
We're taking steps to minimize our environmental impact. We're optimizing energy consumption, actively exploring 
renewable sources, and implementing innovative eco-friendly practices. These actions not only reduce our carbon 
footprint but also contribute to operational excellence.
	
Beyond the environment, the safety and well-being of our patients is paramount. We maintain rigorous protocols to 
ensure the highest standards of care, fostering trust and confidence during every interaction.
	
Waste reduction and resource conservation are also priorities. We've implemented effective waste management 
strategies, embraced recycled materials, and adopted paperless solutions to minimize waste generation and preserve 
precious resources.
	
Our commitment extends beyond the present. We're constantly innovating and improving our sustainability practices, 
driven by a deep desire to create a healthier, greener future for generations to come. We believe in going beyond 
compliance – it's about genuine responsibility towards the environment, society, and all our stakeholders.
	
Together, through collaboration and continuous improvement, we can build a more sustainable and responsible 
future.
8.	
Details of the highest authority responsible for 
implementation and oversight of the Business 
Responsibility policy (ies).
CSR & ESG Committee of the Company is responsible for 
implementation and oversight of the Business Responsibility 
Policies.
The Constitution of the CSR & ESG Committee is as follows:
1.	
Dr. Ramesh Kancharla
	
DIN:00212270
	
Chairman & Managing Director
2.	
Dr. Dinesh Kumar Chirla
	
DIN:01395841
	
Whole-time Director
3.	
Dr. Adarsh Kancharla
	
DIN: 08302615
	
Non-Executive Director
4.	
Dr. Anil Dhawan
	
DIN: 08191702
	
Independent Director
5.	
Ms. Sundari R. Pisupati
	
DIN: 01908852
	
Independent Director
6.	
Mr. Santanu Mukherjee
	
DIN: 07716452
	
Independent Director
09
Business Responsibility & Sustainability Report
Disclosure Questions
P1
P2
P3
P4
P5
P6
P7
P8
P9
9.	
Does the entity have a specified Committee of the 
Board/ Director responsible for decision making 
on sustainability related issues? (Yes / No). If yes, 
provide details.
Yes, the CSR & ESG Committee plays a pivotal role in 
deliberating and making decisions concerning sustainability-
related matters within the company. It serves as the central 
authority responsible for formulating policies and strategies that 
drive the company's sustainability initiatives. With a focus on 
sustainability, the committee evaluates various environmental, 
social, and governance factors, ensuring alignment with 
the company's values and objectives. Through its actions 
and decisions, the committee reinforces the company's 
commitment to ethical business practices and responsible 
citizenship, contributing to positive societal and environmental 
impact.
10	
Details of Review of NGRBCs by the Company
Subject for Review
a. Indicate whether review was undertaken by Director / 
Committee of the Board/ Any other Committee
P1
P2
P3
P4
P5
P6
P7
P8
P9
1	
Performance against above policies and 
follow up action
Committee of the Board
2	
Compliance with statutory requirements of 
relevance to the principles, and rectification 
of any non-compliances
Yes, the Committee of the Board ensures that Company 
complies with all applicable laws and statutory requirement of 
the land it operates in.
Subject for Review
b. Frequency (Annually/ Half yearly/ 
Quarterly/ Any other – please specify)
P1
P2
P3
P4
P5
P6
P7
P8
P9
1	
Performance against above policies and 
follow up action
Annually 
2	
Compliance with statutory requirements 
of relevance to the principles, and the 
rectification of any non-compliances
Quarterly
11.	 Has the entity carried out independent assessment/ evaluation of the working of its policies by an external agency? 
(Yes/No) If yes provide name of the agency.
P1
P2
P3
P4
P5
P6
P7
P8
P9
No
12.	 If answer to question (1) above is “No” i.e., not all Principles are covered by a policy, reasons to be stated:
Disclosure Questions
P1
P2
P3
P4
P5
P6
P7
P8
P9
The entity does not consider the principles material 
to its business (Yes/No)
Not Applicable
The entity is not at a stage where it is in a position 
to formulate and implement the policies on 
specified principles (Yes/No)
The entity does not have the financial or/human and 
technical resources available for the task (Yes/No)
It is planned to be done in the next financial year 
(Yes/No)
Any other reason (please specify)
Integrated Annual Report 2023-24
Rainbow Children's Medicare Limited
10
SECTION C: PRINCIPAL WISE PERFORMANCE DISCLOSURE
PRINCIPLE 1: 
Business should conduct and govern themselves with integrity, and in a manner that is Ethical, Transparent and 
Accountable.
Essential Indicators
1.	
Percentage coverage by training and awareness programmes on any of the principles during the financial year.
Segment
Total number 
of training and 
awareness 
programmes 
held
Topics / principles covered under the 
training and its impact
%age of persons 
in respective 
category covered 
by the awareness 
programmes
Board of Directors
8 The Board of Directors and Key Managerial Personnel 
(KMPs) of the company participate in familiarization and 
awareness programs as an integral part of the board process. 
These programs encompass a range of topics related 
to the business, strategy, Earnings outlook, Operational 
efficiencies, risks, operations, regulations, code of business 
conduct and ethics, as well as economic, environmental, 
social, and governance parameters. Furthermore, regular 
updates are provided to all board members and KMPs to 
keep them informed about company developments, key 
SEBI Regulations, significant regulatory changes, risks, and 
compliance matters.
The Company has also organized an ESG awareness 
session for the Board Members and KMPs.
100%
Key Managerial 
Personnel
Employees other 
than BoD and 
KMPs
3194 Rainbow Code of Conduct covering topics like integrity 
and ethical business practices
100%
Workers
Not Applicable
2.	
Details of fines / penalties /punishment/ award/ compounding fees/ settlement amount paid in proceedings (by 
the entity or by directors / KMPs) with regulators/ law enforcement agencies/ judicial institutions, in the financial 
year, in the following format (Note: the entity shall make disclosures on the basis of materiality as specified in 
Regulation 30 of SEBI (Listing Obligations and Disclosure Obligations) Regulations, 2015 and as disclosed on the 
entity’s website):
Monetary
NGRBC 
Principle
Name of the regulatory/ 
enforcement agencies/ judicial 
institutions
Amount 
(In INR)
Brief of 
the Case
Has an appeal 
been preferred? 
(Yes/No)
Penalty/ Fine
None
Settlement
Compounding fee
Non-Monetary
NGRBC 
Principle
Name of the regulatory/ enforcement 
agencies/ judicial institutions
Brief of the 
Case
Has an appeal been 
preferred? (Yes/No)
Imprisonment
None
Punishment
11
Business Responsibility & Sustainability Report
3.	
Of the instances disclosed in Question 2 above, details of the Appeal/ Revision preferred in case where monetary 
or non-monetary action has been appealed. 
Case Details
Name of the regulatory/ enforcement agencies/ judicial institutions
NA
4.	
Does the entity have an anti-corruption or anti-bribery policy? If yes, provide details in brief and if available, provide 
a web-link to the policy.
	
The Company places a strong emphasis on conducting business in a transparent and ethical manner. To ensure 
compliance with ethical standards, the Company strictly follows all relevant laws, treaties, and regulations that 
prohibit bribery and other corrupt activities. The Whistle blower and Code of Conduct Policies, which address ethics, 
bribery, and corruption, apply to all Rainbow Group, joint ventures, and entities. The same can be accessed at https://
www.rainbowhospitals.in/investors-relations/policies-and-programs
5.	
Number of Directors/KMPs/employees/workers against whom disciplinary action was taken by any law enforcement 
agency for the charges of bribery/ corruption:
FY 2024
FY 2023
Directors
Nil
Nil
KMPs
Nil
Nil
Employees
Nil
Nil
Workers
NA
NA
6.	
Details of complaints with regard to conflict of interest:
FY 2024
FY 2023
Number
Remarks
Number
Remarks
Number of complaints received in relation to issues of 
Conflict of Interest of the Directors
Nil
-
Nil
-
Number of complaints received in relation to issues of 
Conflict of Interest of the KMPs
Nil
-
Nil
-
7.	
Provide details of any corrective action taken or underway on issues related to fines/ penalties / action taken by 
regulators/ law enforcement agencies/ judicial institutions, on cases of corruption and conflicts of interest.
	
Not Applicable as there were zero instances of conflict of interest.
8.	
Number of days of accounts payables ((Accounts payable *365) / Cost of goods/services procured) in the following 
format:
FY 2024
FY 2023
Number of days of accounts payables
183
182
9.	
Open-ness of business*
	
Provide details of concentration of purchases and sales with trading houses, dealers, and related parties along-with 
loans and advances & investments, with related parties, in the following format: 
Parameter
Metrics
FY 2024
FY 2023
Concentration of 
Purchases
a. 	
Purchases from trading houses as 
% of total purchases
Not Applicable owing to the nature of business, 
Rainbow does not procure from trading houses.
b. 	
Number of trading houses where 
purchases are made from 
c. 	
Purchases from top 10 trading 
houses as % of total purchases 
from trading houses
Integrated Annual Report 2023-24
Rainbow Children's Medicare Limited
12
Parameter
Metrics
FY 2024
FY 2023
Concentration of 
Sales
a. 	
Sales to dealers/ distributors as 
% of total sales
Not Applicable owing to the nature of business 
(providing healthcare) Rainbow does not have any 
sales to dealers/distributors.
b. 	
Number of dealers/ distributors 
to whom sales are made
c. 	
Sales 
to 
top 
10 
dealers/ 
distributors as % of total sales to 
dealers/ distributors 
Share of RPTs in
a. 	
Purchases 
(Purchases 
with 
related parties/ Total Purchases) 
0.29%
0.04%
b. 	
Sales (Sales to related parties/ 
Total Sales) 
0.20%
0.17%
c. 	
Loans & advances (Loans & 
advances given to related parties 
/ Total loans & advances)
0.97%
0%
d. 	
Investments 
(Investments 
in 
related parties/ Total Investments 
made) 
8.98%
7.98%
	
*The numbers provided against these KPIs have been reported for RCML Standalone basis
Leadership Indicators
1.	
Awareness programmes conducted for value chain partners on any of the principles during the financial year:
Total number 
of awareness 
programmes held
Topics / principles covered 
under the training
%age of value chain partners covered (by value of business 
done with such partners) under the awareness programmes
-
-
-
2.	
Does the entity have processes in place to avoid/ manage conflict of interests involving members of the Board? 
(Yes/No). If yes, provide details of the same.
	
The company has implemented a comprehensive Code of Conduct specifically designed for Senior Management and 
Board Members, meticulously outlining potential conflict scenarios and offering clear guidelines for their avoidance. 
This Code serves as a cornerstone, embodying the fundamental business practices and behavioural principles that 
underscore the Company’s commitment to integrity. By upholding and adhering to the standards delineated within 
the Code, the Company reinforces its dedication to ethical conduct and business excellence. Ultimately, the Code's 
primary objective is to proactively prevent misconduct and cultivate a culture of unwavering ethical behaviour 
throughout the organization.
13
Business Responsibility & Sustainability Report
PRINCIPLE 2: 
Business should provide goods and services in a manner that is sustainable and safe
Essential Indicators
1.	
Percentage of R&D and capital expenditure (capex) investments in specific technologies to improve the environmental 
and social impacts of product and processes to total R&D and capex investments made by the entity, respectively.
FY 2024
FY 2023 Details of improvements in environmental and social 
impacts
R&D
-
- -
Capex
2.63%
1.64% Operational cost reduction, resource optimisation, 
improvement of Energy efficiencies, Energy sources 
sustainability, 
Carbon 
emission 
reductions 
and 
improving the life span of Assets and so on.
2.	
a.	
Does the entity have procedures in place for sustainable sourcing? (Yes/No)
	
	
Yes
	
b.	
If yes, what percentage of inputs were sourced sustainably?
	
	
The company places utmost importance on ethical sourcing and environmentally sustainable practices to 
mitigate risks within the value chain. This commitment not only reduces environmental impact but also cultivates 
trust and strengthens relationships with suppliers, rooted in integrity. Rainbow Group adopts a centralized 
procurement strategy, providing a "single point of sourcing." The Company procure 96% of the products through 
local distribution channels and partnering with trusted suppliers which in turn helps the company minimize 
transportation risks and ultimately aims to reduces carbon footprint. This localized approach not only strengthens 
the Company’s supply chain resilience but also directly aligns with Rainbow Hospitals' unwavering commitment 
to environmental sustainability.
3.	
Describe the processes in place to safely reclaim your products for reusing, recycling and disposing at the end of life, 
for
	
(a)	
Plastics (including packaging): The Company ensures responsible waste management practices by selling its 
plastic waste to authorized plastic recyclers on a regular basis. As the Company operates in the healthcare 
services industry, the plastic waste generation is minimal. Each unit is equipped with water dispensers with 
disposable paper glass to avoid plastic pet bottles.
	
(b)	
E-waste: The Company ensures responsible waste management practices with its E-waste being disposed of to 
authorised recyclers and proper certificate with details of E-waste issued to individual units.
	
(c)	
Hazardous waste: The Company, as a healthcare service provider, ensures responsible disposal of its biomedical 
waste (BMW) to authorised hazardous waste disposers in compliance with the BMW rules of 2016.
	
(d)	
Other waste: The Company responsibly manages its general waste, including dry and wet waste, by disposing of 
it through municipality-hired vendors who carry out decomposition and recycling of materials/waste based on 
their respective categories.
4.	
Whether Extended Producer Responsibility (EPR) is applicable to the entity’s activities (Yes / No). If yes, whether 
the waste collection plan is in line with the Extended Producer Responsibility (EPR) plan submitted to Pollution 
Control Boards? If not, provide steps taken to address the same.
	
Not Applicable
Integrated Annual Report 2023-24
Rainbow Children's Medicare Limited
14
Leadership Indicators
1.	
Has the entity conducted Life Cycle Perspective / Assessments (LCA) for any of its products (for manufacturing 
industry) or for its services (for service industry)? If yes, provide details in the following format?
	
Not applicable as the Company is in Healthcare Services.
NIC Code
Name of Product 
/Service
% of total 
Turnover 
contributed
Boundary for 
which the 
Life Cycle 
Perspective / 
Assessment was 
conducted
Whether 
conducted by 
independent 
external agency
(Yes/No)
Results 
communicated in 
public domain
(Yes/No)
If yes, provide 
the web-link
Not applicable
2.	
If there are any significant social or environmental concerns and/or risks arising from production or disposal of your 
products / services, as identified in the Life Cycle Perspective / Assessments (LCA) or through any other means, 
briefly describe the same along-with action taken to mitigate the same.
Name of Product / Service
Description of the risk / concern
Action Taken
Not applicable
3.	
Percentage of recycled or reused input material to total material (by value) used in production (for manufacturing 
industry) or providing services (for service industry):
Indicate input material
Recycled or re-used input material to total material
FY2024
FY2023
Not applicable
4.	
Of the products and packaging reclaimed at end of life of products, amount (in metric tonnes) reused, recycled, and 
safely disposed, as per the following format:
FY2024
FY2023
Re-used
Recycled
Safely 
Disposed
Re-used
Recycled
Safely 
Disposed
Plastics 
(including packaging)
-
-
5.86
-
-
1.3
E-waste
-
-
3.03
-
-
1.1
Hazardous waste
-
-
0.20
-
-
283.5
Other waste-
General Waste (Dry & Wet)
-
-
838.04
-
-
636.66
5.	
Reclaimed products and their packaging materials (as percentage of products sold) for each product category.
Indicate product category
Reclaimed products and their packaging materials as % of total products 
sold in respective category
Not applicable
15
Business Responsibility & Sustainability Report
PRINCIPLE 3: 
Business should respect and promote the well-being of all employees, including those in their value chains
Essential Indicators
1.	
a.	
Details of measures for the well-being of employees:
Category
% of employees covered by
Total 
(A)
Health 
insurance
Accident 
insurance
Maternity 
benefits
Paternity 
Benefits
Day Care 
facilities
Number 
(B)
% 
(B / A)
Number 
(C)
% 
(C / A)
Number 
(D)
% 
(D / A)
Number 
(E)
% 
(E / A)
Number 
(F)
% 
(F / A)
Permanent employees
Male
1,663
405
24%
1,663
100%
NA
NA
1,663
100%
1,663
100%
Female
2,277
280
12%
2,277
100%
2277
100%
NA
NA
2,277
100%
Total
3,940
685
17%
3,940
100%
2277
58%
1,663
42%
3,940
100%
Other than Permanent employees
Male
422
259
61%
200
47%
NA
NA
NA
NA
NA
NA
Female
1,113
819
74%
535
48%
NA
NA
NA
NA
NA
NA
Total
1,535
1,078
70%
735
48%
NA
NA
NA
NA
NA
NA
	
b.	
Details of measures for the well-being of workers:
Category
% of workers covered by
Total 
(A)
Health 
insurance
Accident 
insurance
Maternity 
benefits
Paternity 
Benefits
Day Care 
facilities
Number 
(B)
% 
(B / A)
Number 
(C)
% 
(C / A)
Number 
(D)
% 
(D / A)
Number 
(E)
% 
(E / A)
Number 
(F)
% 
(F / A)
Permanent Workers
Male
Not Applicable
Female
Total
Other than Permanent Workers.
Male
Not Applicable
Female
Total
	
c.	
Spending on measures towards well-being of employees and workers (including permanent and other than 
permanent) in the following format-
FY 2024
FY 2023
Cost incurred on well-being measures as a % of total revenue of 
the company 
1.07%
1.04%
2.	
Details of retirement benefits, for Current FY and Previous Financial Year
Benefits
FY 2024
FY 2023
No. of 
employees 
covered 
as a % 
of total 
employees
No. of 
workers 
covered 
as a % 
of total 
workers
Deducted 
and 
deposited 
with the 
authority 
(Y/N/N.A.)
No. of 
employees 
covered 
as a % 
of total 
employees
No. of 
workers 
covered 
as a % 
of total 
workers
Deducted 
and 
deposited 
with the 
authority 
(Y/N/N.A.)
PF
100%
NA
Yes
100%
NA
Yes
Gratuity
100%
NA
NA
100%
NA
NA
ESI
24%
NA
Yes
41%
NA
Yes
Others- please specify
-
-
-
-
-
-
Integrated Annual Report 2023-24
Rainbow Children's Medicare Limited
16
3.	
Accessibility of workplaces
	
Are the premises / offices of the entity accessible to differently abled employees and workers, as per the 
requirements of the Rights of Persons with Disabilities Act, 2016? If not, whether any steps are being taken by the 
entity in this regard.
	
All Rainbow Group hospitals in India adhere to the Rights of Persons with Disabilities Act 2016, ensuring accessibility for 
all employees. This commitment is evident in the implementation of various accessibility measures, such as wheelchair 
ramps and providing assistance when needed. These efforts underscore the company's dedication to inclusivity and 
ensuring that individuals with disabilities can access healthcare facilities and services without hindrance.
4.	
Does the entity have an equal opportunity policy as per the Rights of Persons with Disabilities Act, 2016? If so, 
provide a web-link to the policy.
	
Yes, the Company is committed to maintaining a policy of non-discrimination and enforcing a strong stance against 
any behaviours that contravene its ethics and Code of Conduct. These standards are clearly outlined in the Business 
Responsibility Policy, demonstrating the Company's dedication to promoting a culture of fairness, respect and 
accountability. The same can be accessed at https://www.rainbowhospitals.in/investor-relations/reports/policy/ 
Business%20Responsibility%20Policy.pdf
5.	
Return to work and Retention rates of permanent employees and workers that took parental leave.
Gender
Permanent employees
Permanent workers
Return to work rate
Retention rate
Return to work rate
Retention rate
Male
100%
77%
Not Applicable
Female
97.3%
55.8%
Total 
98.7%
66.2%
6.	
Is there a mechanism available to receive and redress grievances for the following categories of employees and 
worker? If yes, give details of the mechanism in brief
Yes/No (If Yes, then give details of the mechanism in brief)
Permanent Workers
Not Applicable
Other than Permanent 
Workers
Permanent Employees
The company offers employees a comprehensive reporting system for addressing 
concerns, comprising various channels such as unit-level channels, a dedicated whistle 
blower hotline, an anti-sexual harassment channel, and a corporate employee well-
being and grievance channel. These channels operate in accordance with the company's 
established policies, including the Whistle blower Policy, Anti-Sexual Harassment 
Policy, Anti-Discrimination Policy, and Code of Conduct, ensuring that employees have 
avenues to raise their concerns and grievances while upholding ethical standards and 
promoting a safe and inclusive work environment.
Other than Permanent 
Employees
7.	
Membership of employees and worker in association(s) or Unions recognised by the listed entity:
Category
FY 2024
FY 2023
Total 
employees 
/ workers in 
respective 
category (A)
No. of employees 
/ workers in 
respective 
category, who 
are part of 
association(s) or 
Union (B)
% (B / A)
Total 
employees 
/ workers in 
respective 
category 
(C)
No. of employees 
/ workers in 
respective 
category, who 
are part of 
association(s) or 
Union (D)
% (D / C)
Total Permanent 
Employees
3940
0
0
3581
0
0
Male
1663
0
0
1502
0
0
Female
2277
0
0
2079
0
0
Total Permanent 
Worker
Not Applicable
Male
Female
17
Business Responsibility & Sustainability Report
8.	
Details of training given to employees and workers:
Category
FY 2024
FY 2023
Total 
(A)
On Health and 
safety measures
On Skill 
upgradation
Total 
(D)
On Health and 
safety measures
On Skill 
upgradation
No. (B)
% 
(B / A)
No. (C)
% 
(C / A)
No. (E)
% 
(E / D)
No. (F)
% 
(F / D)
Employees
Male
2085
1973
95%
1762
84%
1502
1193
79%
1138
76%
Female
3390
2702
80%
2576
76%
2079
1830
88%
1764
85%
Total
5475
4675
85%
4338
79%
3581
3023
84%
2902
81%
Workers
Male
Not Applicable
Female
Total
9.	
Details of performance and career development reviews of employees and worker:
Category
FY 2024
FY 2023
Total (A)*
No. (B)
% (B / A)
Total (C)
No. (D)
% (D / C)
Employees
Male
1663
1149
69%
1502
1298
86%
Female
2277
1459
64%
2079
1726
83%
Total
3940
2608
66%
3581
3024
84%
Workers
Male
Not Applicable
Female
Total
 
*Only Permanent employees are eligible for performance and career development
10.	 Health and safety management system:
	
a.	
Whether an occupational health and safety management system has been implemented by the entity? 
(Yes/No). If yes, the coverage such system?
	
	
Yes. The safety management system has guidelines that apply to all the Hospitals.
	
b.	
What are the processes used to identify work-related hazards and assess risks on a routine and non-routine 
basis by the entity?
	
	
The company strives to foster a culture of safety excellence, underpinned by a robust occupational health and 
safety management system. This system encompasses stringent protocols for identifying hazards, devising risk 
mitigation strategies, and continuously verifying compliance. Internal audits conducted at regular intervals ensure 
the steadfast adherence to industry-best safety practices. Moreover, the company bolsters its safety framework 
by implementing a Process Safety Management system, thus demonstrating its unwavering commitment to 
prioritizing the well-being and safety of its employees and stakeholders.
	
c.	
Whether you have processes for workers to report the work-related hazards and to remove themselves from 
such risks. (Y/N)
	
	
Yes. The company fosters a proactive safety approach by equipping employees with standardized procedures 
for hazard identification and reporting (SOPs). These SOPs outline risk mitigation strategies to minimize or 
eliminate potential workplace threats. Furthermore, comprehensive occupational health and safety training 
equips employees with the skills to recognize, assess, and effectively address hazards through various risk 
management techniques.
	
d.	
Do the employees/worker of the entity have access to non-occupational medical and healthcare 
services? (Yes/No)
	
	
Yes. The company offers comprehensive health benefits to all employees, including group insurance coverage 
and access to medical services.
Integrated Annual Report 2023-24
Rainbow Children's Medicare Limited
18
11.	 Details of safety related incidents, in the following format:
Safety Incident/Number
Category
FY 2024
FY 2023
Lost Time Injury Frequency Rate (LTIFR) (per one 
million-person hours worked)
Employees
0
0
Workers
NA
NA
Total recordable work-related injuries
Employees
0
0
Workers
NA
NA
No. of fatalities
Employees
0
0
Workers
NA
NA
High consequence work-related injury or ill-health 
(excluding fatalities)
Employees
0
0
Workers
NA
NA
12.	 Describe the measures taken by the entity to ensure a safe and healthy work place.
	
Yes. The Company places utmost importance on the well-being of its employees and ensures a safe and healthy 
workplace through regular training programs. Safety kits, including PPE kits and other necessary equipment, are provided 
to protect staff from contamination. With the majority of hospitals being NABH-approved, the Company adheres to all 
local requirements to ensure compliance and maintain high standards of safety and quality in its operations.
13.	 Number of Complaints on the following made by employees and workers:
FY 2024
FY 2023
Filed 
during the 
year
Pending 
resolution 
at the end 
of year
Remarks
Filed 
during the 
year
Pending 
resolution 
at the end 
of year
Remarks
Working Conditions
0
0
-
0
0
-
Health & Safety
0
0
-
0
0
-
14.	 Assessment for the year:
% of your plants and offices that were assessed (by entity or statutory 
authorities or third parties)
Health and safety practices
100% of our premises are assessed by internal experts to ensure the 
compliance of safety regulations and identification of major improvement areas.
Working Conditions
15.	 Provide details of any corrective action taken or underway to address safety-related incidents (if any) and on 
significant risks/ concerns arising from assessments of health & safety practices and working conditions.
	
The Hospital Unit safety manual serves as a robust guide, detailing precise safety procedures and corrective measures 
for incidents, ensuring swift and uniform responses. Adopting proactive risk management strategies, the hospital 
systematically identifies and addresses potential hazards across all units. This approach fosters a culture of safety and 
preparedness, empowering staff to effectively manage emergencies and uphold the highest standards of patient care.
Leadership Indicators
1.	
Does the entity extend any life insurance or any compensatory package in the event of death of (A) Employees (Y/N) 
(B) Workers(Y/N).
	
Yes. The Company offers a comprehensive benefits package to its employees, which includes Accidental Death and 
insurance and Workers' Compensation coverage. This ensures financial security for employees and their families in the 
unfortunate event of a work-related accident resulting in death.
2.	
Provide the measures undertaken by the entity to ensure that statutory dues have been deducted and deposited by 
the value chain partners.
	
Rainbow Hospitals maintains a robust internal control framework through regular audits that verify the timely remittance 
of all statutory dues. These audits ensure the company's adherence to labour laws and regulations. Furthermore, the 
company leverages the expertise of a dedicated Labour Law Consultant to assess the compliance posture of outsourced 
manpower vendors. This comprehensive approach allows the company to demonstrate its unwavering commitment 
to upholding the highest standards of labour law compliance. By prioritizing these initiatives, the company fosters a 
culture of transparency, accountability, and rigorous adherence to legal requirements across all its operations.
19
Business Responsibility & Sustainability Report
3.	
Provide the number of employees / workers having suffered high consequence work-related injury / ill-health / 
fatalities (as reported in Q11 of Essential Indicators above), who have been are rehabilitated and placed in suitable 
employment or whose family members have been placed in suitable employment.
Total No. of affected 
employees/workers
No. of employees/workers that are rehabilitated 
and placed in suitable employment or whose family 
members have been placed in suitable employment
FY2024
FY2023
FY2024
FY2023
Employees
-
-
-
-
Workers
-
-
-
-
4.	
Does the entity provide transition assistance programs to facilitate continued employability and the management of 
career endings resulting from retirement or termination of employment? (Yes/ No)
	
Currently, the Company does not offer a formal transition assistance program.
5.	
Details on assessment of value chain partners:
% of value chain partners (by value of business done with such partners) 
that were assessed
Health and safety practices
Nil
Working Conditions
Nil
6.	
Provide details of any corrective actions taken or underway to address significant risks/concerns arising from 
assessments of health and safety practices and working conditions of value chain partners.
	
Currently, the company's oversight of health and safety practices, as well as working conditions within its value chain, 
is under evaluation. The company is committed to identifying and implementing best practices to ensure a responsible 
and sustainable supply chain.
Integrated Annual Report 2023-24
Rainbow Children's Medicare Limited
20
PRINCIPLE 4: 
Business should respect the interests of and be responsive to all its stakeholders
Essential Indicators
1.	
Describe the processes for identifying key stakeholder groups of the entity.
	
The Company’s approach to identifying key stakeholders involves recognizing individuals, groups, institutions, or entities 
that significantly influence their business, contribute value, or are integral to their business value chain. These stakeholders 
encompass both internal and external entities, including those with direct and indirect connections to their operations. 
Stakeholders are assessed based on their interest, impact, and involvement in the company's activities. Central to their 
operations is the commitment to meet the needs, interests, and expectations of stakeholders. The Company actively 
listens to their feedback and maintain various communication channels, advocacy platforms, and engagement tools to 
facilitate dialogue. Key stakeholders encompass a diverse range, including employees, investors, suppliers, partners, 
customers, government authorities, healthcare professionals, patients, and the broader community. Recognizing the 
roles, interests, influence, concerns, and expectations of stakeholders is fundamental to their engagement strategy. 
Accordingly, they define the frequency and depth of stakeholder interactions within their organization.
2.	
List stakeholder groups identified as key for your entity and the frequency of engagement with each stakeholder 
group.
Stakeholder 
Group
Whether 
identified as 
Vulnerable & 
Marginalized 
Group (Yes/No)
Channels of communication 
(Email, SMS, Newspaper, 
Pamphlets, Advertisement, 
Community Meetings, Notice 
Board, Website), Other
Frequency of 
engagement 
(Annually/ 
Half yearly/ 
Quarterly / 
others – please 
specify)
Purpose and scope of engagement 
including key topics and concerns 
raised during such engagement
Patients/
Customers
Yes
•	 Customer relationship 
management
•	 Website and social media
•	 Customer support desk
•	 Patient feedback system
•	 Patient satisfaction survey
•	 SMS and helpline desk
•	 Daily/weekly/monthly or 
continuous monitoring 
based on feedback system 
depending on the nature of 
stakeholder engagement
Continuous
•	 Timely availability of services
•	 Quality/efficiency of service
•	 Cost-effectiveness
•	 Innovation in services/products
•	 Hygiene in environment.
•	 Patient data privacy (restrict 
personal data use/shred 
documents)
Employees
No
•	 Emails
•	 Periodic townhalls meetings 
to enable bottom-to-top 
communication
•	 Website
•	 Cultural events
•	 Structured employee surveys
•	 Intranet Portal
•	 Notice board
Continuous
•	 Training and development
•	 Regular company updates
•	 Employee concerns to provide a 
safe, inclusive, and empowering 
workplace for its employees 
that encourages transparent 
engagement and the freedom to 
act, innovate.
Investors
No
•	 Integrated Annual Report
•	 Company‘s Investor Relations 
section of website
•	 Annual general meeting
•	 Quarterly and annual 
presentations and earning 
calls
•	 Announcements to stock 
exchanges
•	 Investor meets 
Quarterly/
ongoing
•	 To ensure transparent and 
effective communication of 
business performance
•	 To address investor / analyst 
queries and concerns
•	 To ensure sound corporate 
governance mechanisms
•	 To provide insights into 
Company’s strategy and 
sustainability initiatives
21
Business Responsibility & Sustainability Report
Stakeholder 
Group
Whether 
identified as 
Vulnerable & 
Marginalized 
Group (Yes/No)
Channels of communication 
(Email, SMS, Newspaper, 
Pamphlets, Advertisement, 
Community Meetings, Notice 
Board, Website), Other
Frequency of 
engagement 
(Annually/ 
Half yearly/ 
Quarterly / 
others – please 
specify)
Purpose and scope of engagement 
including key topics and concerns 
raised during such engagement
Suppliers/
vendors
No
•	 Digital meetings / In person 
meetings.
•	 Supplier forums, partner 
events, calls, e-mail.
Need-based
•	 Quality Assurance in Supply 
Chain
•	 Local Procurement
•	 Performance feedback
•	 Updation about change in 
regulation pertaining to supplies/
services.
•	 To finalize rate contracts and 
request for Quotation rate 
negotiation/ strategic meetings
Government
No
Emails / Community
meetings/ In
person meetings
Need-based
•	 Representations / Perspective 
on change in regulations/ 
upcoming laws
Society
Yes
•	 Social media
•	 CSR
•	 Community building sessions
•	 Awareness campaigns
•	 Health surveys
•	 Discussions on medical issues
•	 Press conferences
•	 Health talks and camps
Need-based
•	 Analysis of the health needs of 
the society
•	 Identifying the gap between 
demand and supply 
•	 Prevention of illnesses
Healthcare 
Professionals
No
•	 Trainings,
•	 One-to-One Physician and 
HOD interactions, Employee 
Experience Surveys
Continuous
•	 To develop State of the art 
infrastructure
•	 To provide best in class medical 
facilities trainings specific to 
their domain
Leadership Indicator
1.	
Provide the processes for consultation between stakeholders and the Board on economic, environmental, and 
social topics or if consultation is delegated, how is feedback from such consultations provided to the Board.
	
During Board meetings, Management consistently updates Board members on stakeholder feedback regarding 
Environmental, Social, and Governance (ESG) matters. This ensures Board members are well-informed about 
stakeholder perspectives on ESG-related issues, enabling informed decision-making. Responsibility for consulting and 
engaging with stakeholders on ESG topics is delegated to specific departments, ensuring ongoing communication 
and collaboration. This inclusive approach fosters transparency and encourages active participation in ESG initiatives. 
By involving relevant departments, the Company promotes effective stakeholder engagement, aligning with its 
commitment to address stakeholder concerns and drive sustainable practices.
2.	
Whether stakeholder consultation is used to support the identification and management of environmental, and 
social topics (Yes / No). If so, provide details of instances as to how the inputs received from stakeholders on these 
topics were incorporated into policies and activities of the entity.
	
Yes, Stakeholder feedback undergoes regular review and discussion with management, leading to the implementation 
of necessary measures. Effective engagement aligns stakeholder needs with organizational objectives, fostering 
shared value. We utilize diverse communication channels to engage stakeholders, comprehending their needs and 
concerns. Patient and employee surveys, industry reports, grievance mechanisms, and ongoing communication 
facilitate appropriate responses and policy adjustments. These efforts ensure continuous improvement and strategic 
development, enhancing relationships and driving positive outcomes for all stakeholders.
3.	
Provide details of instances of engagement with, and actions taken to, address the concerns of vulnerable/ 
marginalized stakeholder groups.
	
The company places a strong emphasis on its commitment to social responsibility and the improvement of patient 
care and community health. By prioritizing the accessibility of quality healthcare, especially for those most in need, 
the company demonstrates its dedication to addressing the concerns of vulnerable and marginalized groups. 
This commitment is reflected in various initiatives and actions aimed at enhancing healthcare services and outcomes 
for these populations.
Integrated Annual Report 2023-24
Rainbow Children's Medicare Limited
22
PRINCIPLE 5: 
Businesses should respect and promote human rights
Essential Indicators
1.	
Employees and workers who have been provided training on human rights issues and policy(ies) of the entity, in the 
following format:
Category
FY 2024
FY 2023
Total (A)
No. of 
employees 
/ workers 
covered 
(B)
% (B / A)
Total (C)
No. of 
employees 
/ workers 
covered 
(D)
% (D / C)
Employees
Permanent
3,940
1518
39%
3,581
1504
42%
Other than permanent
1,535
916
60%
1,279
460
36%
Total Employees
5,475
2434
44%
4,860
1964
40%
Workers
Permanent
Not Applicable
Other than permanent
Total Workers
2.	
Details of minimum wages paid to employees and workers, in the following format:
Category
FY 2024
FY 2023
Total 
(A)**
Equal to 
Minimum Wage
More than 
Minimum Wage
Total 
(D)
Equal to 
Minimum Wage
More than 
Minimum Wage
No. (B)
% 
(B / A)
No. (C)
%
(C / A)
No. (E)
% 
(E / D)
No. (F)
% 
(F / D)
Employees
Permanent
3,193
223
7%
2970
93%
3581
360
10%
3221
90%
Male
1,226
78
6%
1148
94%
1502
196
13%
1306
87%
Female
1,967
145
7%
1822
93%
2079
164
8%
1915
92%
Other than Permanent
1544
-
-
-
-
-
-
-
-
-
Male
424
-
-
-
-
-
-
-
-
-
Female
1120
-
-
-
-
-
-
-
-
-
Workers
Permanent
Not Applicable
Male
Female
Other than Permanent
Male
Female
 
**Total has been taken as per the employees eligible for Minimum Wages as per statutory requirements.
23
Business Responsibility & Sustainability Report
3.	
Details of remuneration/ salary/ wages, in the following format: 
	
a.	
Median remuneration/wages: 
Male
Female
Number
Median remuneration/ 
salary/ wages of 
respective category
Number Median remuneration/ 
salary/ wages of 
respective category
Board of Directors (BoD)
6
1,82,90,338
1
21,50,000
Key Managerial Personnel
3
1,27,70,855
0
0
Employees other than BoD and KMP
1,663
3,44,880
2,277
3,24,000
Workers
Not Applicable
	
b.	
Gross wages paid to females as % of total wages paid by the entity, in the following format:
FY 2024
FY 2023
Gross wages paid to females as % of total wages
47.7%
46.4%
4.	
Do you have a focal point (Individual/ Committee) responsible for addressing human rights impacts or issues caused 
or contributed to by the business? (Yes/No)
	
Yes, the Company is committed to honesty, fairness, and transparency, and it strives to maintain the highest standards 
of ethical behaviour and practise. It actively encourages professionalism and ethical behaviour among its employees 
and has put in place strong measures to foster and support this culture. To guarantee a safe and ethical working 
environment for all, the Company's management takes quick action to investigate and address the issue in accordance 
with its policy.
5.	
Describe the internal mechanisms in place to redress grievances related to human rights issues.
	
The company is steadfastly dedicated to upholding internationally recognized human rights principles and standards. 
Rainbow Hospitals has implemented robust procedures and processes throughout its global operations to safeguard 
against human rights violations.
	
Employees, contractors and service providers can report any suspected violations of the human rights policy by the 
company, its representatives or suppliers and service providers to the relevant executives or senior managers or 
anonymously through Grievance@rainbowhospitals.in.
6.	
Number of Complaints on the following made by employees and workers:
FY 2024
FY 2023
Filed 
during the 
year
Pending 
resolution 
at the end 
of year
Remarks
Filed 
during the 
year
Pending 
resolution 
at the end 
of year
Remarks
Sexual Harassment
Nil
Nil
-
Nil
Nil
-
Discrimination at workplace
Nil
Nil
-
Nil
Nil
-
Child Labour
Nil
Nil
-
Nil
Nil
-
Forced Labour/Involuntary Labour
Nil
Nil
-
Nil
Nil
-
Wages
Nil
Nil
-
Nil
Nil
-
Other human rights related issues
Nil
Nil
-
Nil
Nil
-
7.	
Complaints filed under the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) 
Act, 2013, in the following format:
Particulars
FY 2024
FY 2023
Total Complaints reported under Sexual Harassment on of Women at 
Workplace (Prevention, Prohibition and Redressal) Act, 2013 (POSH)
Nil
Nil
Complaints on POSH as a % of female employees / workers
Nil
Nil
Complaints on POSH upheld
Nil
Nil
Integrated Annual Report 2023-24
Rainbow Children's Medicare Limited
24
8.	
Mechanisms to prevent adverse consequences to the complaint in discrimination and harassment cases.
	
The company prioritizes a safe and ethical workplace, evident through its multifaceted framework comprising a 
Code of Conduct, gender-neutral anti-harassment policy, and robust Business Risk and Responsibility (BRR) policies. 
These mechanisms empower employees to report any human rights concerns confidently. Management pledges to 
thoroughly investigate all reported issues, ensuring corrective actions align with company policies. Moreover, the 
company's policies shield employees from retaliation or employment threats, demonstrating a steadfast commitment 
to fostering a supportive environment where all individuals feel respected and valued.
9.	
Do human rights requirements form part of your business agreements and contracts? (Yes/No)
	
Yes
10.	 Assessment for the year:
% of your plants and offices that were assessed 
(by entity or statutory authorities or third parties)*
Child labour
100%
Forced/involuntary labour 
100%
Sexual harassment 
100%
Discrimination at workplace
100%
Wages
100%
Others –please specity
-
 
*By entity
11.	 Provide details of any corrective actions taken or underway to address significant risks/ concerns arising from the 
assessments at Question 10 above.
	
No significant risks or concerns were found during the assessment.
Leadership Indicators
1.	
Details of a business process being modified / introduced as a result of addressing human rights grievances/
complaints.
	
Even though there were no Human Rights related grievances reported during the financial year, the Company continues 
to monitor, review and update its policies and processes periodically.
2.	
Details of the scope and coverage of any Human rights due-diligence conducted.
	
The company promotes a culture of compliance through ongoing employee education on the Code of Conduct 
delivered via a variety of training programs. This commitment ensures all employees are equipped with the necessary 
knowledge to act ethically and follow company regulations.
3.	
Is the premise/office of the entity accessible to differently abled visitors, as per the requirements of the Rights of 
Persons with Disabilities Act, 2016?
	
The Company is committed to accessibility and inclusion for all employees. Following the Rights of Persons with 
Disabilities Act 2016, all the hospitals in India are designed and equipped to be fully accessible to differently-abled 
individuals. This commitment is reflected in the implementation of various accessibility measures, including wheelchair 
ramps, accessible restrooms, and the provision of support personnel when necessary.
4.	
Details on assessment of value chain partners:
% of value chain partners (by value of business done 
with such partners) that were assessed
Child labour
-
Forced/involuntary labour 
-
Sexual harassment 
-
Discrimination at workplace
-
Wages
-
Others-please specify 
-
5.	
Provide details of any corrective actions taken or underway to address significant risks/ concerns arising from the 
assessments at Question 4 above. 
	
Not Applicable
25
Business Responsibility & Sustainability Report
PRINCIPLE 6: 
Businesses should respect and make efforts to protect and restore the environment
Essential Indicators
1.	
Details of total energy consumption (in Joules or multiples) and energy intensity, in the following format:
Parameter
Unit
FY 2024
FY 2023
From renewable sources
Total electricity consumption (A)
GJ
11760.95
1249.207
Total fuel consumption (B)
GJ
-
 -
Energy consumption through other sources (C)
GJ
-
 -
Total energy consumed from renewable sources 
(A+B+C)
GJ
 11760.95
 1249.20
From non-renewable sources
Total electricity consumption (D)
GJ
75099.04
67643.02
Total fuel consumption (E)
GJ
3111.73
630.21
Energy consumption through other sources (F)
GJ
-
-
Total energy consumed from non-renewable sources 
(D+E+F)
GJ
78210.77
68273.23
Total energy consumed (A+B+C+D+E+F)
GJ
89971.72
69522.43
Energy intensity per rupee of turnover (Total energy 
consumed/ Revenue from Operations)
7.27
6.241
Energy intensity per rupee of turnover adjusted 
for Purchasing Power Parity (PPP) (Total energy 
consumed/ Revenue from operations adjusted for PPP)
166.47
142.8
Energy intensity in terms of physical output 
(in terms of number of beds)
** Note: Total beds include managed beds
43.99
38.94
	
Note: Indicate if any independent assessment/ evaluation/assurance has been carried out by an external agency? (Y/N) If yes, 
name of the external agency: No
2.	
Does the entity have any sites / facilities identified as designated consumers (DCs) under the Performance, Achieve 
and Trade (PAT) Scheme of the Government of India? (Y/N) If yes, disclose whether targets set under the PAT 
scheme have been achieved. In case targets have not been achieved, provide the remedial action taken, if any.
	
No
3.	
Provide details of the following disclosures related to water, in the following format:
Parameter
FY 2024
FY 2023
Water withdrawal by source (in kilolitres)
(i)	
Surface Water
 -
-
(ii)	
Ground Water
 115394.10
 109165
(iii)	
Third Party Water
 24288
 26758
(iv)	
Seawater / desalinated water
 -
 -
(v)	
Others
70414.25
 37495
Total volume of water withdrawal (in kilolitres) (i + ii + iii + iv + v)
210096.35
173418
Total volume of water consumption (in kilolitres)
210096.35
173418
Water intensity per rupee of turnover 
(Total Water consumption / Revenue from operations)
 16.19
15.57
Water intensity per rupee of turnover adjusted for Purchasing Power 
Parity (PPP) (Total water consumption/ Revenue from operations adjusted 
for PPP)
370.65
356.18
Water intensity in terms of physical output (in terms of number of beds)
** Note: Total beds include managed beds
102.73
97.15
	
Note: Indicate if any independent assessment/ evaluation/assurance has been carried out by an external agency? (Y/N) If yes, 
name of the external agency.: No
Integrated Annual Report 2023-24
Rainbow Children's Medicare Limited
26
4.	
Provide the following details related to water discharged:
Parameter
FY 2024
FY 2023
Water discharge by destination and level of treatment (in kilolitres) 
i)	
To surface water
 143387.5 KL
127362.51 KL
	
-	
No treatment
-
-
	
-	
With treatment-please specify level of treatment
143387.5 KL
127362.51 KL, 
after chlorination, 
STP and UV 
filtration
ii)	
To Groundwater
-
-
	
-	
No treatment
-
-
	
-	
With treatment-please specify level of treatment
-
-
iii)	
To Seawater 
-
-
	
-	
No treatment
-
-
	
-	
With treatment-please specify level of treatment
-
-
iv)	
Sent to third-parties
-
-
	
-	
No treatment
-
-
	
-	
With treatment-please specify level of treatment
-
-
v)	
Others
-
-
	
-	
No treatment
-
-
	
-	
With treatment-please specify level of treatment
-
-
Total water discharge (in kilolitres) 
143387.5
127362.51
	
Note: Indicate if any independent assessment/ evaluation/assurance has been carried out by an external agency? (Y/N) If yes, 
name of the external agency: No
5.	
Has the entity implemented a mechanism for Zero Liquid Discharge? If yes, provide details of its coverage and 
implementation.
	
Rainbow Hospitals places environmental responsibility at the forefront of its operations, particularly evident in its 
sustainable water management practices at Greenfield facilities. Through proactive measures such as recycling and 
reusing treated wastewater for operational needs, the company has substantially reduced its freshwater consumption 
while increasing the utilization of recycled water. These efforts align with the principles of Reduce, Reuse, and Recycle 
(3R), showcasing Rainbow Hospitals' commitment to conserving water resources. Additionally, each unit is equipped 
with Sewage Treatment Plants featuring Ultra High filtration systems and Rainwater Harvesting Pits, further emphasizing 
the organization's dedication to sustainable practices.
6.	
Please provide details of air emissions (other than GHG emissions) by the entity, in the following format:
Parameter
Please specify 
unit
FY 2024
FY 2023
NOx
Tonne
0.000001365
0.04
Sox
Tonne
0.000000433
3.6
Particulate matter (PM)
Tonne
0.000000182
Persistent organic compounds (POP)
-
-
-
Volatile organic compounds (VOC)
-
-
-
Hazardous air pollutants (HAP)
-
-
-
Others-please specify
-
-
-
	
Note: Approach for calculating air emissions is different for FY 2024.
	
Note: Indicate if any independent assessment/ evaluation/assurance has been carried out by an external agency? 
(Y/N) If yes, name of the external agency: No
27
Business Responsibility & Sustainability Report
7.	
Provide details of greenhouse gas emissions (Scope 1 and Scope 2 emissions) & its intensity, in the following format:
Parameter
Unit
FY 2024
FY 2023
Total Scope 1 emissions (Break-up of the GHG into 
CO2, CH4, N2O, HFCs, PFCs, SF6, NF3, if available)
Metric tonnes 
of CO2 
equivalent
1712.35
501
Total Scope 2 emissions (Break-up of the GHG into 
CO2, CH4, N2O, HFCs, PFCs, SF6, NF3, if available)
Metric tonnes 
of CO2 
equivalent
12677.14
17477
Total Scope 1 and Scope 2 emission intensity per 
rupee of turnover (Total Scope 1 and Scope 2 GHG 
emissions / Revenue from operations)
tCO2e/rupee 
turnover
1.16
1.61
Total Scope 1 and Scope 2 emission intensity per 
rupee of turnover adjusted for Purchasing Power 
Parity (PPP) (Total Scope 1 and Scope 2 GHG 
emissions / Revenue from operations adjusted for PPP)
tCO2e/rupee 
turnover
26.63
36.93
Total Scope 1 and Scope 2 emission intensity in terms 
of physical output (in terms of number of beds)
** Note: Total beds include managed beds
tCO2e/total 
number of 
beds
7.04
10.07
 
Note: Indicate if any independent assessment/ evaluation/assurance has been carried out by an external agency? (Y/N) If yes, 
name of the external agency: No
8.	
Does the entity have any project related to reducing Green House Gas emission? If Yes, then provide details.
	
The Company has achieved a significant reduction of 2134.6 metric tons of CO2 emissions through a series of targeted 
initiatives. This commitment underscores company’s dedication to environmental responsibility and sustainable 
operations. RCH has opted for following below said Initiatives to mitigate Green House Gas Emissions;
	
•	
Solar Power Generation at Roof Top
	
•	
Solar Hot Water Generations at Roof Top
	
•	
Open Access System for Renewable Energy – Wind & Solar
	
•	
Internet of Things (IOT) Based Building Management System
	
•	
LED lighting system with motion sensor & timer
	
•	
Variable frequency drive installations to conserve energy across hospitals
	
•	
High efficiency chillers
	
•	
EV charger in Hospitals
	
•	
Energy Savings at LB Nagar, Rosewalk and Heart institute with Solar roof top & VFDs respectively
9.	
Provide details related to waste management by the entity, in the following format:
Parameter
FY 2024
FY 2023
Total Waste generated (in metric tonnes)
Plastic waste (A)
5.86
13
E-waste (B)
3.03
1.1
Bio-medical waste
325.72
282.98
Construction and demolition waste (D)
25.42
150
Battery waste (E)
0.09
0.225
Radioactive waste (F)
0
0
Other Hazardous waste. Please specify, if any. (G)
0.112
0.52
Other Non-hazardous waste generated (H). Please specify, if any. 
(Break-up by composition i.e. by materials relevant to the sector) 
(Dry+wet+carton+iron+paper)
838.04
636.657
Total (A+B + C + D + E + F + G + H)
1198.272
1084.482
Waste intensity per rupee of turnover (Total waste generated / Revenue 
from operations)
0.096
0.096
Integrated Annual Report 2023-24
Rainbow Children's Medicare Limited
28
Parameter
FY 2024
FY 2023
Waste intensity per rupee of turnover adjusted for Purchasing Power 
Parity (PPP) (Total waste generated / Revenue from operations adjusted for 
PPP)
2.209
2.203
Waste intensity in terms of physical output (in terms of number of beds)
** Note: Total beds include managed beds
0.58
0.60
For each category of waste generated, total waste recovered through recycling, re-using or other recovery 
operations (in metric tonnes)
Category of waste
i)	
Recycled
-
-
ii)	
Re-used
-
-
iii)	
Other recovery operations
-
-
Total
For each category of waste generated, total waste disposed by nature of disposal method (in metric tonnes)
Category of waste
i)	
Incineration
-
-
ii)	
Landfilling
-
-
iii)	
Other disposal operations
1135.18
1072.782
Total
1135.18
1072.782
 
Note: Indicate if any independent assessment/ evaluation/assurance has been carried out by an external agency? (Y/N) If yes, 
name of the external agency: No
10.	 Briefly describe the waste management practices adopted in your establishments. Describe the strategy adopted by 
your company to reduce usage of hazardous and toxic chemicals in your products and processes and the practices 
adopted to manage such wastes.
	
The Company adheres to the guidelines outlined in the Central Pollution Control Board (CPCB) Biomedical Waste 
Management Rules of 2016 for the disposal of biomedical waste (BMW). Authorized collectors sanctioned by the 
PCB are engaged for the segregation and disposal of BMW. Additionally, in accordance with the directives issued 
by the Ministry of Environment, Forest, and Climate Change (MoEF), the Company has implemented an e-waste 
policy covering all electronic and electrical goods, which are disposed of through authorized vendors. General waste, 
including paper, cardboard, plastics, tins, and scrap, is disposed of as needed. Wastewater is treated using Sewage 
Treatment Plants (STP) as per hospital policy, with the recycled treated wastewater utilized for flush tanks, gardening, 
and cellar cleaning with minimal human contact.
11.	 If the entity has operations/offices in/around ecologically sensitive areas (such as national parks, wildlife 
sanctuaries, biosphere reserves, wetlands, biodiversity hotspots, forests, coastal regulation zones etc.) where 
environmental approvals / clearances are required, please specify details in the following format: 
	
The Company does not have any operations in ecologically sensitive areas.
S. No.
Location of 
operations/
offices
Type of
operations
Whether the conditions of environmental approval / clearance are 
being complied with? (Y/N) 
If no, the reasons thereof and corrective action taken, if any. 
Not Applicable
12.	 Details of environmental impact assessments of projects undertaken by the entity based on applicable laws, in the 
current financial year:  
	
The Company has not undertaken any EIA of project during the year.
Name and brief 
details of project
EIA 
Notification 
No.
Date
Whether conducted by 
independent external agency 
(Yes / No)
Results communicated 
in public domain 
(Yes / No) 
Relevant 
Web link
Not Applicable
29
Business Responsibility & Sustainability Report
13.	 Is the entity compliant with the applicable environmental law/ regulations/ guidelines in India; such as the Water 
(Prevention and Control of Pollution) Act, Air (Prevention and Control of Pollution) Act, Environment protection 
Act and rules thereunder (Y/N). 
	
Yes, the Company is in compliance with all the relevant statutory regulations and guidelines. There were no cases of 
non-compliances recorded during the financial year.
	
If not, provide details of all such non-compliances, in the following format: 
S. No.
Specify the law / regulation 
/ guidelines which was not 
complied with
Provide details 
of the non-
compliance
Any fines / penalties / action taken 
by regulatory agencies such as 
pollution control boards or by courts
Corrective action 
taken, if any
Not Applicable
Leadership Indicators
1.	
Water withdrawal, consumption and discharge in areas of water stress (in kilolitres):
	
For each facility/ plant located in areas of water stress, provide the following information:
	
i)	
Name of the area
	
ii)	
Nature of operations
	
iii)	
Water withdrawal, consumption and discharge in the following format:
	
	
Not applicable as none of the company’s facilities fall under water stress areas
Parameter
FY 2024
FY 2023
Water withdrawal by source (in kilolitres)
i)	
Surface Water
 -
 -
ii)	
Ground Water
 -
 -
iii)	
Third Party Water
 -
 -
iv)	
Seawater / desalinated water
 -
 -
v)	
Others
-
-
Total volume of water withdrawal (in kilolitres) 
 -
 -
Total volume of water consumption (in kilolitres)
 -
 -
Water intensity per rupee of turnover (Total Water consumption / 
Revenue from operations)
 -
 -
Water intensity (optional) – the relevant metric may be selected by 
the entity
 -
 -
Water discharge by destination and level of treatment (in kilolitres)
i)	
Into Surface water
-
-
	
-	
No treatment
-
-
	
-	
With treatment – please specify level of treatment
-
-
ii)	
Into Groundwater
-
-
	
-	
No treatment
-
-
	
-	
With treatment – please specify level of treatment
-
-
iii)	
Into Seawater
-
-
	
-	
No treatment
-
-
	
-	
With treatment – please specify level of treatment
-
-
iv)	
Sent to third-parties
-
-
	
-	
No treatment
-
-
	
-	
With treatment – please specify level of treatment
-
-
v)	
Others
-
-
	
-	
No treatment
-
-
	
-	
With treatment – please specify level of treatment
-
-
Total water discharged (in kilolitres)
-
-
	
	
Note: Indicate if any independent assessment/ evaluation/assurance has been carried out by an external agency? (Y/N) If 
yes, name of the external agency. : No
Integrated Annual Report 2023-24
Rainbow Children's Medicare Limited
30
2.	
Please provide details of total Scope 3 emissions and its intensity, in the following format:
	
The Company is currently not mapping its Scope 3 emissions however shall undertake the same in the 
forthcoming periods.
Parameter
Unit
FY 2024
FY 2023
Total Scope 3 emissions (Break-up of the GHG into 
CO2, CH4, N2O, HFCs, PFCs, SF6, NF3, if available)
-
-
-
Total Scope 3 emissions per rupee of turnover
-
-
-
Total Scope 3 emission intensity (optional) – the 
relevant metric may be selected by the entity
-
-
-
 
Note: Indicate if any independent assessment/ evaluation/assurance has been carried out by an external agency? (Y/N) If yes, 
name of the external agency: No
3.	
With respect to the ecologically sensitive areas reported at Question 11 of Essential Indicators above, provide 
details of significant direct & indirect impact of the entity on biodiversity in such areas along-with prevention and 
remediation activities.
	
There has been no significant direct or indirect impact on biodiversity.
4.	
If the entity has undertaken any specific initiatives or used innovative technology or solutions to improve resource 
efficiency, or reduce impact due to emissions / effluent discharge / waste generated, please provide details of the 
same as well as outcome of such initiatives, as per the following format:
Sr. 
No
Initiative 
undertaken
Details of the initiative (Web-link, 
if any, may be provided along-with 
summary)
Outcome of the initiative
1
 Solar Roof top
 https://www.rainbowhospitals.in/esg
430277 units of electricity generated.
Emission Avoided – 365.7 Tons
2
 Solar Water 
heaters
599544 units of energy saved with solar water
heaters and to ensure energy efficiency and
reduction of the emissions.
Emission Avoided - 509.6 Tons
3
Open Access - 
Renewable Energy
-
Energy Utilized – 2836655 KWH
Emission Avoided - 2411 Tons
5.	
Does the entity have a business continuity and disaster management plan? Give details in 100 words/ web link.
	
Rainbow Hospitals upholds a stringent business continuity plan, aligned with ISO 27001:2013. It shields against 
disruptions, emphasizing swift recovery of information assets post-system restoration. The focus is on mitigating 
operational impact during extended outages. With resilience ingrained, Rainbow ensures uninterrupted patient care, 
embodying preparedness as a way of life.
6.	
Disclose any significant adverse impact to the environment, arising from the value chain of the entity. What mitigation 
or adaptation measures have been taken by the entity in this regard.
	
The Company has not conducted any impact assessment of value chain partners w.r.t. direct or indirect impacts on 
the environment.
7.	
Percentage of value chain partners (by value of business done with such partners) that were assessed for 
environmental impacts.
	
The Company has not undertaken any assessments of its value chain partners.
31
Business Responsibility & Sustainability Report
PRINCIPLE 7: 
Businesses, when engaging in influencing public and regulatory policy, should do so in a manner that is responsible and 
transparent
Essential Indicators
1.	
a.	
Number of affiliations with trade and industry chambers/associations.
	
	
3 (Three)
 
b. 
List the top 10 trade and industry chambers/associations (determined based on the total members of such 
body) the entity is a member of/ affiliated to.
S. 
No.
Name of the trade and industry chambers/ associations
Reach of trade and industry chambers/ 
associations (State/National)
1
Associated Chambers of Commerce and Industry of India 
(ASSOCHAM)
National
2
Directorate of Medical Education
National
3
Telangana Super Specialty Hospitals Association (TSSHA)
State
2.	
Provide details of corrective action taken or underway on any issues related to anti-competitive conduct by the 
Company, based on adverse orders from regulatory authorities.
	
During the year under review, no adverse orders have been passed by any regulatory body relating to the anti-competitive 
conduct by the Company.
Name of the authority
Brief of the case
Corrective action taken
Not Applicable
Leadership Indicators
1.	
Details of public policy positions advocated by the entity
S. 
No.
Public 
Policy 
advocated
Method 
resorted for 
such advocacy
Whether information 
available in public 
domain? (Yes/ No)
Frequency of Review by Board 
(Annually/ Half yearly/Quarterly/
Others- please specify)
Web Link, if 
available
-
-
-
-
-
-
PRINCIPLE 8: 
Businesses should promote inclusive growth and equitable development
Essential Indicators
1.	
Details of Social Impact Assessments (SIA) of projects undertaken by the entity based on applicable laws, in the 
current financial year
Name and brief 
details of project
SIA 
Notification 
No.
Date of 
notification
Whether conducted by 
independent external 
agency (Yes / No)
Results communicated 
in public domain 
(Yes / No)
Relevant Web 
link
Not Applicable
Integrated Annual Report 2023-24
Rainbow Children's Medicare Limited
32
2.	
Provide information on project(s) for which ongoing Rehabilitation and Resettlement (R&R) is being undertaken by 
your entity, in the following format:
S. 
No.
Name of Project 
for which R&R is 
ongoing
State
District
No. of Project Affected 
Families (PAFs)
% of PAFs 
covered by 
R&R
Amount paid to 
PAFs in the FY 
(In INR)
Not Applicable
3.	
Describe the mechanisms to receive and redress grievances of the community.
	
The Company prioritizes inclusivity, ensuring everyone feels heard and respected. Rainbow believes in creating a 
welcoming environment where all stakeholders, including employees, customers, and community members, are valued. 
To uphold this commitment, the Company has established a whistle-blower channel. This channel serves as a platform 
for anyone to raise concerns or grievances anonymously. Rainbow takes these concerns seriously and is dedicated to 
addressing them promptly and transparently. Through open communication and accountability, the Company strives to 
cultivate trust and foster a culture of mutual respect within the organization and with the communities which it serves.
4.	
Percentage of input material (inputs to total inputs by value) sourced from suppliers:
Particulars
FY 2024
FY 2023
Directly sourced from MSMEs/ small producers
83%
22%
Directly from within India
100%
100%
5.	
Job creation in smaller towns – Disclose wages paid to persons employed (including employees or workers 
employed on a permanent or non-permanent / on contract basis) in the following locations, as % of total wage cost
Location
FY 2024
FY 2023
Rural
-
-
Semi-urban
-
-
Urban
-
-
Metropolitan 
100%
100%
Leadership indicators
1.	
Provide details of actions taken to mitigate any negative social impacts identified in the Social Impact Assessments 
(Reference: Question 1 of Essential Indicators above):
	
Not Applicable
Details of negative social impact identified
Corrective action taken
-
-
2.	
Provide the following information on CSR projects undertaken by your entity in designated aspirational districts as 
identified by government bodies: None
S. 
No.
State
Aspirational District
Amount spent (In INR)
-
33
Business Responsibility & Sustainability Report
3.	
a.	
Do you have a preferential procurement policy where you give preference to purchase from suppliers comprising 
marginalized/ vulnerable group? (Yes/ No)
	
	
No. 
	
b.	
From which marginalized /vulnerable groups do you procure?
	
	
Not Applicable
	
c.	
What percentage of total procurement (by value) does it constitute?
	
	
Not Applicable
	
The quality of the materials is of prime importance to the sector the Company operates in. Though the Company 
does not have a preferential procurement policy, it does not discriminate on the basis on caste, creed or religion while 
selecting the supplier.
4.	
Details of the benefits derived and shared from the intellectual properties owned or acquired by your entity (in the 
current financial year), based on traditional knowledge
S. 
No.
Intellectual Property based 
on traditional knowledge
Owned/ Acquired 
(Yes/No)
Benefit shared
(Yes / No)
Basis of calculating 
benefit share
-
-
-
-
-
5.	
Details of corrective actions taken or underway, based on any adverse order in intellectual property related disputes 
wherein usage of traditional knowledge is involved.
Name of authority
Brief of the Case
Corrective action taken
-
-
-
6.	
Details of beneficiaries of CSR Projects:
S. 
No
CSR Project
No. of persons benefitted from 
CSR Projects
% of beneficiaries from vulnerable 
and marginalized groups
Please refer CSR Report of the Annual Report at page no 128
Integrated Annual Report 2023-24
Rainbow Children's Medicare Limited
34
PRINCIPLE 9: 
Businesses should engage with and provide value to their consumers in a responsible manner
Essential indicators
1.	
Describe the mechanisms in place to receive and respond to consumer complaints and feedback.
	
The Company has implemented a comprehensive feedback collection system, allowing customers to share their 
input through various channels. Through the Company’s in-house application, customers can provide feedback on 
both outpatient (OP) and inpatient (IP) services, with IP feedback gathered at the hospital before discharge, and OP 
feedback obtained via an SMS link sent to their registered phone number. Additionally, customers have the option to 
share feedback by visiting the Company’s website, contacting the call center, or emailing queries@rainbowhospitals.in.
	
Collected feedback is then shared with relevant stakeholders for appropriate action. The organization is currently working 
on centralizing and modernizing this process by introducing new channels and touchpoints for feedback collection.
2.	
Turnover of products and/ services as a percentage of turnover from all products/service that carry information 
about:
As a percentage to total turnover
Environmental and social parameters relevant to the product
Not Applicable
Safe and responsible usage
Recycling and/or safe disposal
3.	
Number of consumer complaints in respect of the following
FY 2024
Remarks
 FY 2023
Remarks
Received 
during the 
year
Pending 
resolution at 
end of year
Received 
during the 
year
Pending 
resolution at 
end of year
Data privacy
NIL
NIL
-
NIL
NIL
-
Advertising
NIL
NIL
-
NIL
NIL
-
Cyber-security
NIL
NIL
-
NIL
NIL
-
Delivery of essential services
2629
9
-
1065
15
-
Restrictive Trade Practices
NIL
NIL
-
NIL
NIL
-
Unfair Trade Practices
NIL
NIL
-
NIL
NIL
-
Other
NIL
NIL
-
NIL
NIL
-
4.	
Details of instances of product recalls on account of safety issues:
	
Not Applicable
Number
Reasons for recall
Voluntary recalls
-
-
Forced recalls
-
-
5.	
Does the entity have a framework/ policy on cyber security and risks related to data privacy? (Yes/No) If available, 
provide a web-link of the policy.
	
Yes, Rainbow Hospitals demonstrates a steadfast commitment to protecting individuals' privacy and information 
security through its comprehensive cybersecurity framework and data privacy policy. The organization ensures 
adherence to industry best practices and regulatory standards, employing continuous monitoring, risk assessments, 
and employee training to mitigate cyber threats. With a focus on maintaining the trust of patients and stakeholders, 
Rainbow Hospitals provides transparency and clarity on its privacy practices. The privacy policy, accessible via the 
weblink on the company's website (https://www.rainbowhospitals.in/terms-and-conditions), outlines how personal 
information is handled and protected, reinforcing Rainbow Hospitals' dedication to privacy and security.
35
Business Responsibility & Sustainability Report
6.	
Provide details of any corrective actions taken or underway on issues relating to advertising, and delivery of essential 
services; cyber security and data privacy of customers; re-occurrence of instances of product recalls; penalty / 
action taken by regulatory authorities on safety of products / services.
	
The Company is dedicated to upholding top-tier network security standards through the deployment of cutting-edge 
Palo Alto firewall systems. These systems offer thorough monitoring, auditing, and alert capabilities, enabling 
organisation’s IT team to swiftly identify and address potential risks. Having implemented these advanced security 
protocols, Rainbow operates confidently, assured of the robust protection of its network infrastructure.
7.	
Provide the following information relating to data breaches:
	
a.	
Number of instances of data breaches
	
	
NIL
	
b.	
Percentage of data breaches involving personally identifiable information of customers
	
	
NIL
	
c.	
Impact, if any, of the data breaches
	
	
NIL
Leadership indicators
1.	
Channels/platforms where information on products and services of the entity can be accessed (provide web link, if 
available).
	
The website features details regarding the company's healthcare services. The link for the website is 
https://www.rainbowhospitals.in/
Linkedin:
https://in.linkedin.com/company/rainbow-hospital
Instagram:
https://www.instagram.com/rainbowchildrenshospitals/?hl=en
Twitter:
https://twitter.com/rch_india?lang=en
Facebook:
https://www.facebook.com/rainbowchildrenshospitals/
2.	
Steps taken to inform and educate consumers about safe and responsible usage of products and/ or services.
	
Not Applicable owing to the nature of business.
3.	
Mechanisms in place to inform consumers of any risk of disruption/ discontinuation of essential services.
	
The company has hired a prominent consulting firm to conduct a Risk Assessment study to pinpoint potential 
vulnerabilities. Upon identification, necessary measures were promptly taken to resolve the issues. Furthermore, to 
safeguard the availability of its website, the Company chose AWS as its hosting platform, benefiting from default 
Business Continuity Planning (BCP) strategies.
4.	
a.	
Does the entity display product information on the product over and above what is mandated as per local laws? 
(Yes/No/Not Applicable) If yes, provide details in brief.
	
	
Not Applicable
	
b.	
Did your entity carry out any survey with regard to consumer satisfaction relating to the major products / 
services of the entity, significant locations of operation of the entity or the entity as a whole? (Yes/No)
	
	
Yes, Rainbow Children's Medicare Limited regularly conducts surveys to gauge consumer satisfaction with our 
major products/services and significant locations of operation. Specifically, it utilizes SMS feedback mechanisms 
to capture patient feedback on our Outpatient Department (OPD) services and call center services. The Company 
also gathers NPS ratings through both OP and IP feedback forms, and also tracks its online GMB rating.
